Glucotrack, Inc. has announced the successful completion of its first human clinical study for a continuous blood glucose monitor (CBGM), which is uniquely placed in the subclavian vein for real-time ...
Patients receiving 300 mg farabursen demonstrated a mean halting of height-adjusted total kidney volume (htTKV) growth over 4 months Exploratory analysis of patients from high-dose cohorts ...
HALIFAX, NS, April 9, 2026 /CNW/ - Clarke Inc. (the "Company" or "Clarke") (TSX: CKI) is pleased to announce the successful completion of its normal course issuer bid ("NCIB"), initially announced on ...
Last month, the New York State Department of Environmental Conservation announced that a major aquatic rehabilitation project was completed with high success. It was an experimental aquatic habitat ...
VANCOUVER, BC, March 2, 2026 /PRNewswire/ - GoldMining Inc. (TSX: GOLD) (NYSE American: GLDG) ("GoldMining" or the "Company") congratulates its majority owned ...